Ireland IEEPA Tariff Refund Recovery
Ireland is the United States’ top source of pharmaceutical imports and a major exporter of medical devices and technology goods. IEEPA tariffs on Irish-origin goods have been ordered refunded. CAPE Phase 3 is live as of October 6, 2026 — file your claim now.
Ireland consistently ranks as one of the United States’ top import partners by value, driven almost entirely by high-value, low-volume goods: finished pharmaceuticals (Pfizer, Bristol-Myers Squibb, Alexion, AbbVie all manufacture in Ireland), medical devices (Medtronic, Boston Scientific, Abbott), software and tech licensing, and specialty chemicals. Because Irish pharmaceutical exports to the U.S. are extremely high-value per entry, even a modest IEEPA rate translated into very large absolute duty amounts — and therefore large potential refunds through CAPE.
CAPE Phase 3, live October 6, 2026, covers finally liquidated entries. The short turnaround time for pharmaceutical entries means a large share of Ireland importer entries from 2025 are already in finally liquidated status.
Irish pharma entries frequently involve related-party transactions and transfer pricing arrangements that affect the dutiable value declared on CF 7501. We review the original valuation basis to ensure the CAPE refund reflects the actual IEEPA duty paid — not a transfer price that was later adjusted.
Ireland importers often have a small number of entries with very high per-entry duty amounts. Even a handful of pharmaceutical or biologic shipments can represent millions in IEEPA duties. A single-entry audit approach maximizes recovery on Ireland portfolios.
Irish-manufactured goods sometimes involve API sourced from multiple countries or formulation steps split between Ireland and EU partners. Country-of-origin must be clearly established for each entry — we verify origin documentation before CAPE submission to avoid rejection.
We compile all Irish-origin entry summaries, ranked by dutiable value. Pharmaceutical and biologic entries — the highest-exposure category — are reviewed first. Each entry is checked for correct HTS classification, IEEPA duty rate, and origin documentation.
Related-party transactions are reviewed for transfer pricing adjustments and their impact on dutiable value. Origin documentation is verified for any entry with multi-country formulation or packaging steps. Entries that clear both reviews are packaged for CAPE Phase 3 submission.
All filings are coordinated with or executed through a licensed customs broker in accordance with 19 C.F.R. Part 111. We prepare the complete CAPE submission package and manage all CBP correspondence through final disbursement.
Advisory only — not legal advice. Customs brokerage services are coordinated with or executed through a licensed customs broker in accordance with 19 C.F.R. Part 111. The Tariff Bureau LLC is not itself a licensed customs broker. Governing law: Georgia. Arbitration: Fulton County, GA.
IEEPA tariffs on Irish goods have been ordered refunded. CAPE Phase 3 is now live — act before CBP processing windows close.
Free Assessment Learn More